Dr. Childress is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4000 E Charleston Blvd
Ste 130
Las Vegas, NV 89104Phone+1 702-968-4000Fax+1 702-838-6749
Education & Training
- Medical University of South CarolinaFellowship, Child and Adolescent Psychiatry, 1991 - 1993
- Medical University of South CarolinaResidency, Psychiatry, 1987 - 1991
- Medical University of South CarolinaClass of 1987
Certifications & Licensure
- NV State Medical License 1997 - 2025
- SC State Medical License 1988 - 1997
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Clinical Trials
- Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD Start of enrollment: 2005 Jun 01
- NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD Start of enrollment: 2004 Sep 01
- PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Viloxazine Extended-Release Administered With Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Phase 4, Open-Label Trial.Ann Childress, Kobby Asubonteng, Georgette Cox, Jami Earnest, Kimberley Hayman
Journal of Child and Adolescent Psychopharmacology. 2025-02-27 - Safety and Efficacy of Brexpiprazole in the Treatment of Irritability Associated with Autism Spectrum Disorder: An 8-Week, Phase 3, Randomized, Double-Blind, Placebo-C...Caroline Ward, Ann Childress, Krista Martinko, Dalei Chen, Klaus Groes Larsen
Journal of Child and Adolescent Psychopharmacology. 2025-02-19 - 1 citationsQuality of Life and Outcomes Associated with Adverse Effects in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder and Their Parents/Caregivers.Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Louise Yu
Journal of Child and Adolescent Psychopharmacology. 2025-02-01
Press Mentions
- CDC: Half of People with ADHD Diagnosed in AdulthoodOctober 15th, 2024
- Corium's Novel ADHD Medication AZSTARYS® (Serdexmethylphenidate and Dexmethylphenidate) Had No Clinically Significant Impact on Children's Weight and Height Growth RateMay 22nd, 2023
- A Once-Daily Stimulator for ADHD Is Safe, Effective for 1 YearMarch 10th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: